Nova Patents
IL304026B2

A pharmaceutical formulation comprising 1-(4-fluoro-phenyl)-4-((6br,10as)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one and uses thereof

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority and filed
  2. Published
  3. Today

50 members in 12 offices

This recordMember, by publication date2 more offices are in the list below

Members50

Family members, oldest first
DocumentOfficeKind
CA3054841A1CanadaA1
US2018271862A1United States of AmericaA1
WO2018175969A1World Intellectual Property Organization (WIPO)A1
AU2018240540A1AustraliaA1
IL268970AIsraelA
IL268970D0IsraelD0
CN110430879AChinaA
KR20190132671ARepublic of KoreaA
MX2019011329AMexicoA
EP3600325A1European Patent Office (EPO)A1
BR112019019875A2BrazilA2
JP2020512328AJapanA
US10716786B2United States of AmericaB2
US2020375988A1United States of AmericaA1
EP3600325A4European Patent Office (EPO)A4
RU2019133676ARussian FederationA
US11052083B2United States of AmericaB2
RU2019133676A3Russian FederationA3
AU2018240540B2AustraliaB2
MX387784BMexicoB
US2021361648A1United States of AmericaA1
AU2021286423A1AustraliaA1
RU2767410C2Russian FederationC2
RU2022103663ARussian FederationA
KR102398194B1Republic of KoreaB1
KR20220066988ARepublic of KoreaA
JP2022084651AJapanA
MX2021013640AMexicoA
MX395214BMexicoB
JP7132939B2JapanB2
MX2022010797AMexicoA
CN110430879BChinaB
CN116327770AChinaA
AU2021286423B2AustraliaB2
IL268970B1IsraelB1
IL304026AIsraelA
US2023301995A1United States of AmericaA1
US11806347B2United States of AmericaB2
IL268970B2IsraelB2
US2024016802A1United States of AmericaA1
IL304026B1IsraelB1
KR102708440B1Republic of KoreaB1
KR20240141212ARepublic of KoreaA
IL304026B2This recordIsraelB2
MX387784BMexicoB
MX395214BMexicoB
US12268686B2United States of AmericaB2
US12336989B2United States of AmericaB2
US2025275962A1United States of AmericaA1
CN116327770BChinaB